Literature DB >> 12713951

The binding mode of the DNA bisintercalator luzopeptin investigated using atomic force microscopy.

Torunn Berge1, E Lucy Haken, Michael J Waring, Robert M Henderson.   

Abstract

The luzopeptins are DNA bisintercalating antibiotics that contain a decadepsipeptide to which are attached two quinoline chromophores. We have used atomic force microscopy (AFM) to investigate the interaction between luzopeptin B and DNA in an attempt to shed light on the binding mode of this antibiotic. AFM images provided contour lengths which were used as a direct measure of bisintercalation. Binding of luzopeptin B was investigated using two different DNA sequences, one having a GC content of 42% and the other 59%, which revealed a higher degree of bisintercalation into the DNA sequences having the lower GC content. The measured increment in contour length was found to plateau at values corresponding to binding of one drug molecule every 40 and 72 bp to the 42 and 59% GC sequences, respectively. In addition to the length increase, a higher proportion of DNA molecules displaying complex morphology was observed as the concentration of luzopeptin was increased. Such molecules were not included in the measurements of contour length. We propose that the various manifestations of complex morphology arise from both inter- and intramolecular cross-linking of the DNA caused by binding of luzopeptin, providing direct evidence of cross-linked species by AFM imaging.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12713951     DOI: 10.1016/s1047-8477(03)00015-7

Source DB:  PubMed          Journal:  J Struct Biol        ISSN: 1047-8477            Impact factor:   2.867


  4 in total

1.  Exploring the interaction of ruthenium(II) polypyridyl complexes with DNA using single-molecule techniques.

Authors:  Aleksandra Mihailovic; Ioana Vladescu; Micah McCauley; Elaine Ly; Mark C Williams; Eileen M Spain; Megan E Nuñez
Journal:  Langmuir       Date:  2006-05-09       Impact factor: 3.882

2.  PT-ACRAMTU, a platinum-acridine anticancer agent, lengthens and aggregates, but does not stiffen or soften DNA.

Authors:  Samrat Dutta; Matthew J Snyder; David Rosile; Kristen L Binz; Eric H Roll; Jimmy Suryadi; Ulrich Bierbach; Martin Guthold
Journal:  Cell Biochem Biophys       Date:  2013       Impact factor: 2.194

Review 3.  Biosynthetic modularity rules in the bisintercalator family of antitumor compounds.

Authors:  Javier Fernández; Laura Marín; Raquel Alvarez-Alonso; Saúl Redondo; Juan Carvajal; Germán Villamizar; Claudio J Villar; Felipe Lombó
Journal:  Mar Drugs       Date:  2014-05-09       Impact factor: 5.118

4.  Profound Nanoscale Structural and Biomechanical Changes in DNA Helix upon Treatment with Anthracycline Drugs.

Authors:  Aleksandra Kaczorowska; Weronika Lamperska; Kaja Frączkowska; Jan Masajada; Sławomir Drobczyński; Marta Sobas; Tomasz Wróbel; Kinga Chybicka; Radosław Tarkowski; Sebastian Kraszewski; Halina Podbielska; Wojciech Kałas; Marta Kopaczyńska
Journal:  Int J Mol Sci       Date:  2020-06-10       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.